Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
Take Tell Us What YOU Think! Take The Body's Visitor Survey!
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

GlaxoSmithKline AIDS Drugs Show Promise

From U.S. Centers for Disease Control and Prevention

February 23, 2001

An AIDS vaccine developed by GlaxoSmithKline has been shown to stave off the disease in monkeys for over a year. Human Phase I clinical tests are expected to start later this year. If the product proves successful in human testing, Glaxo may combine the vaccine with a cocktail of its existing AIDS drugs. Merck, VaxGen, Aventis, and Chiron are among the other companies that have tested or are testing HIV vaccines.


Other CDC News for February 23, 2001

Reproductive Health and STDs Among Clients of a Women's Health Mobile Clinic in Rural Bali, Indonesia

Offer to Sell AIDS Drugs at a Discount in Africa Is Met With Caution, Uncertainty

GlaxoSmithKline AIDS Drugs Show Promise

Advertisement
UK Mulls Tax Breaks to Attack Third World Disease 		Confined Patient's Case May Fuel New [Florida] Laws

[Florida] County's New AIDS Cases Rank 5th in U.S. Metro Areas

Germany to Give Kyrgyzstan 5m Marks to Combat TB

South African AIDS Campaign Targets Pre-Teen Sex
Primary and Secondary Syphilis -- United States, 1999


Adapted from:
Wall Street Journal (www.wsj.com)
02/23/01 P. B9

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
 

Advertisement